Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 6 art units • 6 examiners • 0 of 7 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Koninklijke Nederlandse Akademie Van Wetenschappen manages a portfolio with 6 pending office actions in the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 5 distinct examiners and 4 distinct art units. The presence of 5 distinct examiners indicates that the company's applications are being reviewed by several different individuals. With 4 distinct art units involved, the prosecution of these 6 pending office actions is spread across multiple administrative divisions.
The busiest examiner for the company is SCHUBERG, LAURA J, who is responsible for 2 busiest examiner pending actions. These 2 busiest examiner pending actions are part of the total workload currently managed by the company. The 5 distinct examiners provide a variety of feedback for the company's filings in the Biotechnology & Pharmaceuticals sector. Practitioners should note that having 4 distinct art units involved means the company must adhere to the specific practices of various technical groups. This distribution reduces the impact of any single examiner's preferences on the overall portfolio.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (29%) |
| §112 only | 1 (14%) |
| Double-patenting only | 1 (14%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHUBERG, LAURA J | 2 | 23.6% | +37.0% |
| LIPPOLIS, ALEXANDRA ROSE | 1 | 46.9% | +59.0% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
| TINSLEY, BRENDAN THOMAS | 1 | 58.7% | +73.9% |
| LANDAU, SHARMILA GOLLAMUDI | 1 | 11.1% | +4.6% |
| GOUGH, TIFFANY MAUREEN | 1 | 31.6% | +46.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 146d overdue |
| 18254179 | Ribosomal profiling in single cells | BUCHANAN, BAILEY CHEYENNE | 9d overdue |
| 18264587 | Curing disease by transcription regulatory gene editing | LIPPOLIS, ALEXANDRA ROSE | — |
| 17410126 | Culture Medium | LANDAU, SHARMILA GOLLAMUDI | — |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 146d overdue |
| 18254179 | Ribosomal profiling in single cells | BUCHANAN, BAILEY CHEYENNE | 9d overdue |
| 18264587 | Curing disease by transcription regulatory gene editing | LIPPOLIS, ALEXANDRA ROSE | — |
| 17611561 | IMPROVED CULTURE METHOD USING INTEGRIN AGONIST | TINSLEY, BRENDAN THOMAS | — |
| 17059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | GOUGH, TIFFANY MAUREEN | — |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | — |
| Art Unit | Apps |
|---|---|
| 1631 | 2 |
| 1637 | 1 |
| 1682 | 1 |
| 1634 | 1 |
| 1653 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18264587 | Curing disease by transcription regulatory gene editing | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103§112 | Final Rejection | — | Pending | Aug 08, 2023 |
| 18254179 | Ribosomal profiling in single cells | BUCHANAN, BAILEY CHEYENNE | 1682 | §102§103 | Final Rejection | 9d overdue | Pending | May 24, 2023 |
| 17611561 | IMPROVED CULTURE METHOD USING INTEGRIN AGONIST | TINSLEY, BRENDAN THOMAS | 1634 | §103 | Non-Final OA | — | Pending | Nov 15, 2021 |
| 17410126 | Culture Medium | LANDAU, SHARMILA GOLLAMUDI | 1653 | §103 | Final Rejection | — | Pending | Aug 24, 2021 |
| 17059965 | MATURE AIRWAY ORGANOIDS, METHODS OF MAKING AND USES THEREOF | GOUGH, TIFFANY MAUREEN | 1651 | §112 | Final Rejection | — | Pending | Nov 30, 2020 |
| 16113445 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 1631 | §103§112DP | Final Rejection | — | Pending | Aug 27, 2018 |
| 15654243 | CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS | SCHUBERG, LAURA J | 1631 | DP | Non-Final OA | 146d overdue | Pending | Jul 19, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial